Records containing: Hypercholesterolemia, Familial
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-22Real-World Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab in Italy
-
CLINICAL_TRIALS study record update · 2026-02-12Screening for Familial Hypercholesterolemia in Children
-
CLINICAL_TRIALS study record update · 2025-05-09Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry
-
CLINICAL_TRIALS study record update · 2024-12-17Impact of Genetic Testing and Motivational Counseling on the Adherence to Healthy Lifestyle and Hypolipidemic Therapy and Efficiency of Cascade Screening in Patients With Familial Hypercholesterolemia (GENMOTIV-FH)
-
CLINICAL_TRIALS study record update · 2024-11-26Clinical Decision Support for Familial Hypercholesterolemia: a Cluster Randomized Trial in the Primary Care Setting
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-08-15An Open-Label, Worldwide, Treatment Use Study to Provide Ezetimibe 10 Mg/Day to Patients With Homozygous Familial Hypercholesterolemia or Homozygous Sitosterolemia
-
CLINICAL_TRIALS study record update · 2024-07-19PET Imaging of Inflammation and Lipid Lowering Study
-
CLINICAL_TRIALS study record update · 2024-03-13Diet Quality and Coronary Artery Calcification in Adults With Heterozygous Familial Hypercholesterolemia
-
CLINICAL_TRIALS study record update · 2024-01-30Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 Therapy in Patients With Statin-resistant Familial Hypercholesterolemia
-
CLINICAL_TRIALS study record update · 2022-07-28Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI: Cross-over Study in Patients With Cardiovascular Disease and Severe Dyslipidemia
-
CLINICAL_TRIALS study record update · 2022-01-14Evaluating the Efficacy of Different Electronic Medical Record Alerts to Increase Pediatric Lipid Screening Across a Large Integrated Health System
-
CLINICAL_TRIALS study record update · 2021-05-17A Kinetic Study Investigating Lipoprotein Metabolism Before and After the Administration of REGN1500, an ANGPTL3 Inhibitor, in Patients With Homozygous Familial Hypercholesterolemia. A Sub-study for Subjects Enrolled in the R1500-CL-1331 Clinical Trial
-
CLINICAL_TRIALS study record update · 2021-03-08Subclinical Atherosclerosis in Patients With Familial Hypercholesterolemia Treated With Evolocumab®
-
CLINICAL_TRIALS study record update · 2020-12-10Is Family Screening Improved by Genetic Testing of Familial Hypercholesterolemia
-
CLINICAL_TRIALS study record update · 2020-03-06Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia
-
CLINICAL_TRIALS study record update · 2019-08-28A 1-Year, Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Assess the Efficacy and Tolerability of Anacetrapib When Added to Ongoing Statin Therapy With or Without Other Lipid Modifying Medication(s) in Patients With Heterozygous Familial Hypercholesterolemia
-
CLINICAL_TRIALS study record update · 2016-08-03A Phase 2, Double-Blind, Placebo-Controlled, Dose Escalation Study to Assess the Safety, Efficacy, and Pharmacokinetics of ISIS 301012 as Add-on Therapy in Heterozygous Familial Hypercholesterolemia Subjects
-
CLINICAL_TRIALS study record update · 2016-08-03A Phase 2, Open-Label, Dose Escalation Study to Assess the Safety and Efficacy of ISIS 301012 as Add-on Therapy in Homozygous Familial Hypercholesterolemia Subjects
-
CLINICAL_TRIALS study record update · 2016-02-18ClinicalTrials.gov study NCT00005168
-
CLINICAL_TRIALS study record update · 2015-09-29A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Tolerability and Efficacy of AMG 145 on LDL-C in Subject With Heterozygous Familial Hypercholesterolemia
-
CLINICAL_TRIALS study record update · 2015-09-04Non-interventional Study: Safety and Efficacy of the DALI LDL-adsorber and MONET-lipoprotein Filter
-
CLINICAL_TRIALS study record update · 2015-04-22Phase 3 Multi-Center, Double-Blind, Randomized, Parallel Group, Carotid B-Mode Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety and Tolerability of Fixed Combination CP-529,414/Atorvastatin, Administered Orally, Once Daily (QD) for 24 Months, Compared With Maximally Tolerated Atorvastatin Therapy Alone, in Subjects With Heterozygous Familial Hypercholesterolemia.
-
CLINICAL_TRIALS study record update · 2013-12-04A Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ER Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia
-
CLINICAL_TRIALS study record update · 2012-04-27ClinicalTrials.gov study NCT00000594
-
CLINICAL_TRIALS study record update · 2009-09-02A Worldwide, Double-Blind, Randomized, Placebo-Controlled Study of MK0524A 2g Coadministered With Intensive LDL-C Lowering Therapy Compared to Intensive LDL-C Lowering Therapy Alone on Carotid Artery Intima Media Thickening (cIMT) in Patients With Heterozygous Familial Hypercholesterolemia (heFH)